Trademark Overview
On Thursday, December 18, 2008, a trademark application was filed for SATIFA with the United States Patent and Trademark Office. The USPTO has given the SATIFA trademark a serial number of 77636082. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, March 9, 2009. This trademark is owned by Glaxo Group Limited. The SATIFA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines